December 3, 2025
1 min read

Excelsior collects $95M on mission to accelerate discovery, production of small molecules

Excelsior Sciences, which spun out of investment firm Deerfield Management, has roped in $95 million to scale its chemical synthesis “smart bloccs” platform, invest in its internal pipeline and forge partnerships across the industry, including in therapeutics and materials science.

Leave a Reply

Your email address will not be published.

Previous Story

STAT+: Independent doctors get a new advocacy group as skepticism of health giants grows

Next Story

Former CDC official returns to local health care after resigning

Previous Story

STAT+: Independent doctors get a new advocacy group as skepticism of health giants grows

Next Story

Former CDC official returns to local health care after resigning

Latest from Blog

ROFI Drives New Approach to Crop Nutrition

With input costs continuing to pressure farm budgets, some growers are making difficult decisions to reduce fertilizer application rates. While that strategy may ease upfront expenses, it is also accelerating a broader
Go toTop